The Global Consortium of Entrepreneurship Centers is a group of more than 250 university entrepreneurship programs that is headquartered at Rice University’s Jones Graduate School of Business. Photo courtesy of Rice

A Houston-based academic group called out top universities and programs from around the world — including one in Houston and another in Texas — that are excelling in educating future entrepreneurs at the Global Consortium of Entrepreneurship Centers Conference last month.

The GCEC is a consortium of more than 250 university entrepreneurship programs that is headquartered at Rice University’s Jones Graduate School of Business, which has been named a top entrepreneurship program itself time and time again.

The group's annual conference was hosted at the University of Nevada, Las Vegas, in October, and more than 550 member representatives attended, according to a statement from Rice. In addition to talks, break out sessions and collaboration time, 14 universities were awarded top honors at the event.

Houston Community College's entrepreneurial initiatives won in the Excellence in Specialty Entrepreneurship Education category. The office is known for signature programs like its annual business plan competition, which has been running since 2008. It is also home to the Minority Business Development Agency, created by a grant from the Department of Commerce in 2013, and the MBDA Pandemic Recovery Center.

Additionally, the HCC Alief Hayes Campus is in partnership with the Goldman Sachs 10,000 Small Businesses program, providing 100 hours of instruction and advising and access to capital and an alumni network.

The Texas A&M University System also won in the Outstanding Contributions to Venture Creation category along with the University of St. Thomas (Minnesota). TAMU was recognized for its TEES DeepTech Ventures program. The hands-on training program operated out of Doha, Qatar last November.

Meanwhile Babson College's Arthur M. Blank Center for Entrepreneurship and Iowa State University's Pappajohn Center for Entrepreneurship were awarded the most prestigious honor at the conference. The universities received the The Nasdaq Center for Entrepreneurial Excellence Award. This was the first year that two programs received the award based on student body sizes of less than or more than 5,000 students.

Duncan Moore, a professor at the University of Rochester’s William E. Simon Graduate School of Business Administration, and Carol Reeves, associate vice provost for entrepreneurship at the University of Arkansas’ Sam M. Walton College of Business, received legacy awards for their contributions to entrepreneurship education.

Other winners included:

  • Outstanding Emerging Entrepreneurship Center (schools with less than 5,000 students)
    • Lafayette College, Dyer Center for Innovation and Entrepreneurship
  • Outstanding Emerging Entrepreneurship Center (schools with more than 5,000 students)
    • James Madison University, Gilliam Center for Entrepreneurship
    • Nova Southeastern University, Alan B. Levan-NSU Broward Center of Innovation
  • Exceptional Activities in Entrepreneurship Across Disciplines
    • Northeastern University, Center for Entrepreneurship Education
  • Excellence in Entrepreneurship Teaching and Pedagogical Innovation
    • Stanford University, Stanford Technology Ventures Program
  • Outstanding Student Engagement & Leadership (schools with less than 5,000 students)
    • London Business School, Institute of Entrepreneurship and Private Capital
  • Outstanding Student Engagement & Leadership (schools with more than 5,000 students)
    • Marquette University, 707 Hub
  • Exceptional Contributions in Entrepreneurship Research
    • Florida Atlantic University, Adams Center for Entrepreneurship
  • GCEC Center of Entrepreneurial Leadership
    • UNLV, Troesh Center for Entrepreneurship and Innovation
The 2023 GCEC Conference will be held in Dallas next October at the University of Texas at Dallas.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

This Houston suburb named one of 10 newest boomtowns in U.S.

Booming 'Burb

What do you get when you combine a city's surge in population, housing growth, and economy? For the Houston suburb of Conroe, it adds up to being America's No. 9 newest boomtown, according to a new survey from SmartAsset.

The personal finance website's just-released report analyzed more than 400 U.S. cities with populations of 65,000 or more to identify places experiencing rapid growth based on five-year changes in economic output, housing units, and labor force size.

Texas is home to the second-highest concentration of new boomtowns in America with 18 out of 75 located in the Lone Star State. Only Florida ranks higher than Texas by just one.

However, Texas nearly locked out the top five most bustling boomtowns in America. Austin suburb Georgetown topped the list, and its Central Texas neighbors New Braunfels (No. 2) and Leander (No. 4) ranked close behind. Dallas-Fort Worth mid-city Lewisville claimed the No. 5 spot. Lehi, Utah ranked in third place.

Conroe has soared in popularity as one of America's most sought-after suburbs over the last several years, boosted by its renter-friendliness and its livability among the millennial generation.

Conroe has seen a 37 percent increase in housing units from 2019 to 2024, with its labor force growing by 33 percent during that time. SmartAsset also determined that Montgomery County's economic output grew at compound annual rates of 4.9 percent.

The report says population booms and "expanding business activity" can create "visible momentum" for an up-and-coming city, but these fast changes can alter a city in ways residents may not expect.

"In recent years, some American cities stand out for attracting people, investment and development at a pace that sets them apart," the report said. "Boomtown status does not mean growth benefits everyone equally, but it does reflect a city’s expanding economic capacity and the new opportunities that come with it."

America's top 10 new boomtowns are:

  • No. 1 – Georgetown
  • No. 2 – New Braunfels
  • No. 3 – Lehi, Utah
  • No. 4 – Leander
  • No. 5 – Lewisville
  • No. 6 – Palm Coast, Florida
  • No. 7 – Nampa, Idaho
  • No. 8 – McKinney
  • No. 9 – Conroe
  • No. 10 – Frisco
---

This article originally appeared on CultureMap.com.

Houston brain health co. secures $6.5M for rare disease study

neuro funding

Houston-based Goldenrod Therapeutics, part of Fannin Partners' portfolio, has announced the initial close of a $6.5 million series seed preferred stock round.

The round was led by Ataxia Ventures and an affiliate of Fannin, according to a news release.

Goldenrod Therapeutics plans to use the funding to support manufacturing, formulation optimization, IND-enabling studies and a Phase I study of its drug to treat brain inflammation, known as 11h.

The study will consider how 11h, which blocks the enzyme PDE4, could treat Friedreich’s ataxia (FA), a rare genetic disease that affects movement, speech and balance. To date, other PDE4 inhibitors have proven to regulate neuroinflammation and neuronal signaling, but have had adverse gastrointestinal side effects or have not reached enough of the central nervous system, according to Goldenrod.

The company says its 11h is expected to have "broad applicability" with limited emetric side effects.

“Our 11h program is a next-generation, orally bioavailable, brain-penetrant PDE4 inhibitor, where researchers overcame longstanding limitations associated with earlier PDE4 inhibitors," Dr. Dev Chatterjee, CEO of Goldenrod, said in the news release. "We believe this creates the potential for a best-in-class therapy for Friedreich’s Ataxia and a potential foundation for development across multiple neurodegenerative and neuroinflammatory disorders.”

11h was first developed at the University of Nebraska Medical Center (UNeMed). Houston-based Fannin Partners in-licensed the product 2020 and landed SBIR Phase I funding to support its initial development for opioid use disorder soon after.

Goldenrod has also received funding to study 11h's effectiveness for multiple sclerosis, methamphetamine addiction and cocaine addiction.

Goldenrod says it is developing 11h to target a variety of neurological and inflammatory conditions, including Alzheimer's disease, multiple sclerosis, ALS, substance use disorders, Batten disease, pain and traumatic brain injury.